Evidence map›Paper›PMID 32098891›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2020

Family Study Designs Informed by Tumor Heterogeneity and Multi-Cancer Pleiotropies: The Power of the Utah Population Database.

Heidi A Hanson, Claire L Leiser, Michael J Madsen, John Gardner, Stacey Knight, Melissa Cessna, Carol Sweeney, Jennifer A Doherty, Ken R Smith, Philip S Bernard and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Deep Transcriptome Profiling of Multiple Myeloma Using Quantitative Phenotypes.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Heidi A HansonHuntsman Cancer Institute, University of Utah, Salt Lake City, Utah. heidi.hanson@hci.utah.edu.
Claire L LeiserHuntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
Michael J MadsenHuntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
John GardnerHuntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
Stacey KnightIntermountain Healthcare, Salt Lake City, Utah.ORCID 0000-0003-0092-7327
Melissa CessnaIntermountain Biorepository, Intermountain Healthcare, Salt Lake City, Utah.
Carol SweeneyHuntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
Jennifer A DohertyHuntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
Ken R SmithHuntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
Philip S BernardHuntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
Nicola J CampHuntsman Cancer Institute, University of Utah, Salt Lake City, Utah.ORCID 0000-0002-4788-1998
University of Utah · USIntermountain Healthcare · USUniversity of Washington · US

Funding

UTAH REGIONAL CANCER CENTERP30CA042014 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Jared P Rutter · 1986 to 2026
$72.6M
Utah Building Interdisciplinary Resreach Careers in Women's Health Career Development ProgramK12HD085852 · NICHD · UNIVERSITY OF UTAH · PI VARNER, MICHAEL W. · 2015 to 2019
$2.3M
Subtyping Bladder Cancer: A Multi-omic, Exposure-informed, Genealogical Approach (MErGE)K07CA230150 · NCI · UNIVERSITY OF UTAH · PI HANSON, HEIDI ANNE · 2018 to 2021
$683k
NCI NIH HHS HHSN261201100016INCI NIH HHS HHSN261201800016CNCI NIH HHS HHSN261201800016INCI NIH HHS K07 CA230150NCI NIH HHS P30 CA042014NICHD NIH HHS K12 HD085852
6 · The paper itself

Abstract

backgroundPreviously, family-based designs and high-risk pedigrees have illustrated value for the discovery of high- and intermediate-risk germline breast cancer susceptibility genes. However, genetic heterogeneity is a major obstacle hindering progress. New strategies and analytic approaches will be necessary to make further advances. One opportunity with the potential to address heterogeneity via improved characterization of disease is the growing availability of multisource databases. Specific to advances involving family-based designs are resources that include family structure, such as the Utah Population Database (UPDB). To illustrate the broad utility and potential power of multisource databases, we describe two different novel family-based approaches to reduce heterogeneity in the UPDB.

methodsOur first approach focuses on using pedigree-informed breast tumor phenotypes in gene mapping. Our second approach focuses on the identification of families with similar pleiotropies. We use a novel network-inspired clustering technique to explore multi-cancer signatures for high-risk breast cancer families.

resultsOur first approach identifies a genome-wide significant breast cancer locus at 2q13 [

conclusionsOur results suggest pedigree-informed tumor phenotypes can map genes for breast cancer, and that various different cancer pleiotropies exist for high-risk breast cancer pedigrees. IMPACT: Both methods illustrate the potential for decreasing etiologic heterogeneity that large, population-based multisource databases can provide.

Indexed as

Genetic Predisposition to DiseaseChromosome MappingDatabases, FactualFemaleGenetic HeterogeneityGenetic LinkageGenetic LociHumansMaleMedical History TakingNeoplasmsPedigreeRegistriesUtah

Identifiers

PMID32098891
PMCPMC7168701
OpenAlexW3007757164

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.